[Influence of the change in the dose of Clofibrate Spofa and interruption of treatment on the lipid level of blood serum in persons with hyperlipemia].
D000328:Adult; D001161:Arteriosclerosis / Q000517:prevention & control; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged
D008055:Lipids; D002784:Cholesterol; D002994:Clofibrate
Vplyv zmeny dávky Clofibratu Spofa a prerusenia liecby na hladinu lipodov krvného séra u osôb hyperlipidémiou.